Skip Nav Destination
Neuroimmunomodulation Viewpoints –
RESEARCH
Neuroimmunomodulation
About this Journal
Journal Metrics
Impact Factor: 2.4 | |
CiteScore: 4.8 | |
Acceptance Rate: 46% | |
Time to final decision: 10 weeks |
News & Highlights
Neuroimmunomodulation Viewpoints –
Pillar Articles Series: The Transformation of Pavlov's Theory into Immunology
Gold Open Access Publication
All manuscripts submitted to the journal from September 15, 2022, and accepted for publication will carry the Open Access license CC BY-NC 4.0 or the license mandated by a funder. Upon acceptance, an Article Processing Charge (APC) will be levied.
New Editor-in-Chief: Rainer Straub
Learn more about the plans of Prof. Rainer Straub, the Editor-in-Chief of Neuroimmunomodulation, in the editorial: New Editor-in-Chief’s Note: The Past and the Future
Check Out Our Article Collections
Best of Neurodegenerative Diseases
Neuroinflammation in infectious Diseases
Neuroinflammation in Neurodegenerative and Psychiatric Diseases
Articles
Editor's Choice